Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03912285Phase 1Completed
Phase 1, open-label trial of amlodipine and losartan in hypertension (HTN), sponsored by Korea University Anam Hospital. Primary endpoints: Area under the plasma concentration-time curve for a dosing interval at steady state at day 46 and Maximum plasma concentration at steady state at day 46. Started Jan 2008; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03912285.